| BCBS Florida Coverage Guidelines | Tezepelumab-ekko (Tezspire) (09-J4000-13) | 2026-07-01 |
| BCBS Florida Coverage Guidelines | Tildrakizumab-asmn (Ilumya®) Injection (09-J3000-04) | 2026-07-01 |
| BCBS Florida Coverage Guidelines | Tofacitinib (Xeljanz®, Xeljanz® XR) Oral (09-J1000-86) | 2026-07-01 |
| BCBS Florida Coverage Guidelines | Ublituximab-xiiy (Briumvi™) (09-J4000-45) | 2026-07-01 |
| BCBS Florida Coverage Guidelines | Upadacitinib Tablets (Rinvoq®) and Oral (09-J3000-51) | 2026-07-01 |
| BCBS Florida Coverage Guidelines | Ustekinumab Products (Stelara® and (09-J1000-16) | 2026-07-01 |
| BCBS Florida Coverage Guidelines | Vedolizumab (Entyvio®) Injection and (09-J2000-18) | 2026-07-01 |
| BCBS Florida Coverage Guidelines | Velmanase alfa-tycv (Lamzede) intravenous (09-J4000-50) | 2026-07-01 |
| UHC UMR Medical and Drug | Home Health, Skilled, and Custodial Care Services – Commercial and Individual Exchange Medical Policy | 2026-07-01 |
| Ambetter Health Texas Superior Medicaid Clinical | Bone-Anchored Hearing Aid | 2026-07-01 |